Heartlink ECMO Centre, Glenfield Hospital, Leicester, United Kingdom.
ASAIO J. 2013 Sep-Oct;59(5):517-9. doi: 10.1097/MAT.0b013e31829f5e9f.
We describe our novel technique of Pump Controlled Retrograde Trial Off that relies on the retrograde flow to maintain circuit integrity and allow a longer trial off from venoarterial extracorporeal membrane oxygenation support without circuit clot formation or significant patient hemodynamic compromise. This technique avoids the insertion of an arteriovenous bridge and the need to clamp the circuit. We present data on five neonatal patients who were trialled off using this method.
我们描述了一种新的泵控逆行试验关闭技术，该技术依赖于逆行血流来维持回路完整性，并允许在没有回路血栓形成或显著患者血液动力学受损的情况下，更长时间地从静脉-动脉体外膜肺氧合支持中脱机。该技术避免了插入动静脉桥和夹闭回路的需要。我们介绍了使用这种方法进行脱机试验的五例新生儿患者的数据。
